Industry News
Gardasil vaccine may offer protection from prostate cancer
Vaccinating young males against human papilloma virus might not only slow the spread of the virus and cervical cancer in women, but may also help protect men from prostate cancer. [ + ]
AusBiotech responds to NSW’s draft Manufacturing Industry Action Plan
AusBiotech has undertaken extensive consultation with its NSW medical technology members through an open consultation forum and private meetings and responded to the draft NSW Manufacturing Industry Action Plan. [ + ]
Kavanagh lends marketing experience to Nanosonics’ board
Newly-appointed Nanosonics (ASX:NAN) director Michael Kavanagh will offer his experience introducing new products into the healthcare market in order to see the company succeed on the world stage. [ + ]
Start-up gets backing for stroke rehab tool
UniQuest's latest start-up SMART Arm has secured investment support to launch its eponymous product, a device for improving arm function in stroke victims. [ + ]
Lifting malaria’s deadly veil: mystery solved in quest for vaccine
Researchers at the Burnet Institute have made a major breakthrough in the quest for a vaccine against malaria, which causes up to one million deaths each year. [ + ]
Bioniche developing synthetic cow fertility product
Bioniche Life Sciences (ASX:BNC) could be on the road to developing the world's first entirely synthetic FSH product for increasing fertility rates in cows, proof-of-concept stage data suggests. [ + ]
Vale Professor Ralph Slayter AC, Australia’s first Chief Scientist
Australia’s first Chief Scientist, Professor Ralph Slatyer AC, sadly passed away last week at the age of 83. Born and raised in Perth, Professor Slatyer contributed a great deal to Australian science and left behind a lasting legacy. [ + ]
pSivida signs first evaluation deal for eye treatment
pSivida (ASX:PVA) has scored another deal this week, with a major biopharmaceutical company signing up to evaluate the company's Tethadur opthalmic technology. [ + ]
New ASX listing rules to support maturing biotechs
As part of a range of initiatives to improve the competitiveness of Australia’s financial markets, the Australian Securities Exchange (ASX) has finalised new listing rules to help make it easier for small to medium size companies to raise capital for investment. [ + ]
Alchemia set to receive share of profits from fondaparinux sales
Alchemia Limited (ASX:ACL) is due to start receiving a share of the profits from US sales of its anticoagulant product, generic fondaparinux. [ + ]
NSW Science and Engineering Awards open for nomination
Scientists and engineers in NSW should get their nominations in by 5pm, 31 August 2012 for the 2012 NSW Science and Engineering Awards to be in the running for the prizes, worth $55,000. [ + ]
CathRx borrows to cover short term expenses
CathRx (ASX:CXD) has taken a $1m loan to cover short term expenses until it can finalise a more substantial capital raising, due within a couple of months. [ + ]
Scientex launches its new website
Scientex’s new website, to be launched in August 2012, will allow website visitors to access product, technical and application information quickly and easily. [ + ]
NSW’s top scientists and researchers urged to nominate for $55,000 prize
Acting NSW Premier and Minister for Trade and Investment Andrew Stoner has called for nominations for the 2012 NSW Science and Engineering Awards to recognise and reward the state’s leading scientists, engineers and researchers. [ + ]
Osprey Medical packs $18m cash after IPO
Medical device company Osprey Medical (ASX:OSP) is still cashed up from its 20 million IPO on the ASX, despite recording a cash outflow for the June quarter of $1.4 million. [ + ]
